Form 4: Synchrony Financial Director Roy A. Guthrie Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Roy A. Guthrie reports acquiring 957 shares of Synchrony Financial common stock at $43.12 per share on March 31, 2024.
Summary
- On March 31, 2024, Roy A. Guthrie, a director of Synchrony Financial, acquired 957 shares of common stock at a price of $43.12 per share.
- Following this transaction, Mr. Guthrie directly owns 54,196 shares of Synchrony Financial common stock.
- Mr. Guthrie also indirectly owns 10,000 shares through Guthrie 2012 Investments LP, for which he serves as Investment Manager, but disclaims beneficial ownership except to the extent of his direct pecuniary interest.
- The report also mentions restricted stock units that will vest in full on March 31, 2025, each representing a contingent right to receive one share of Synchrony Financial common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The purchase of shares by a director suggests confidence, but it's a relatively small transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The vesting of restricted stock units on March 31, 2025, indicates a future increase in the number of shares held by the reporting person.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.
Comparison to Industry Standards
- Comparing insider transactions to those of peers like Capital One or American Express could provide a broader context.
- Analyzing the volume and frequency of insider trading activity across the financial services sector can offer insights into overall market sentiment.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of transaction: Acquisition of 957 shares of common stock. |
| 03/31/2025 | Vesting date for restricted stock units. |
| 04/02/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.